In this edition of 5QQ, we speak with Julien de Salaberry, founder and CEO of Galen Growth, the company built to bring structure, transparency, and accountability to a rapidly expanding digital health ecosystem. From launching HealthTech Alpha—an analytics platform that blends clinical, commercial, regulatory, and investment data— to championing benchmarking and data transparency, Julien shares how structured insights are helping investors, healthcare leaders, and innovators cut through the hype, make smarter bets, and drive measurable impact in the age of GenAI and next-gen therapeutics.
1. What inspired you to found Galen Growth, and how has your vision evolved with the growing complexity of digital health innovation?
When I founded Galen Growth, the digital health ecosystem was still in its formative years—full of promise but lacking in structure, transparency, and accountability. It was clear that healthcare stakeholders were flying blind: overwhelmed by hype, under-informed by data. We saw a critical need for a purpose-built intelligence platform that could decode the noise and enable more confident decisions. Since then, the space has exploded in scale and complexity. Our vision has evolved from just mapping the ecosystem to empowering our clients—pharmaceutical firms, investors, insurers, and health systems—with real-time, clinically relevant, and benchmarkable insights that fuel better outcomes and accelerate innovation.
2. What key benefits do structured data and insights bring to evaluating startups, partnerships, and strategic planning in healthtech?
Structured data is the foundation for scalable, objective decision-making. In a sector as nuanced and fragmented as digital health, it’s not enough to know what a company does—you need to understand how well it performs across clinical, commercial, and regulatory dimensions. Structured insights allow decision makers to assess startups on merit, spot emerging trends early, identify partnership value pools, and build robust strategic plans rooted in facts, not gut feel. They also reduce the risk of costly missteps by enabling apples-to-apples comparisons across an increasingly global and dynamic landscape.
3. How are analytics platforms like HealthTech Alpha helping healthcare leaders and investors identify high-potential digital health companies and improve ROI?
HealthTech Alpha delivers a 360-degree view of digital health ventures—linking clinical validation, commercial traction, regulatory progress, and investment signals in one unified platform. By surfacing ventures that are not only innovative but also execution-ready, we help our clients cut through hype cycles and identify the companies most likely to deliver ROI, whether that’s in the form of improved patient outcomes, operational efficiencies, or financial returns. Our analytics also power scenario planning, portfolio benchmarking, and competitive landscaping, allowing leaders to make smarter bets, faster.
4. What role do data transparency and benchmarking play in building trust and supporting evidence-based decisions across the global healthtech ecosystem?
Transparency and benchmarking are critical to fostering accountability and trust, both of which are in short supply in a rapidly evolving sector. Without transparent data, it’s difficult to distinguish substance from spin. Benchmarking adds another layer by enabling stakeholders to evaluate ventures, portfolios, and even entire market segments against clear, objective criteria. This not only raises the bar for digital health ventures but also equips investors, partners, and regulators with the confidence to act decisively and responsibly. Ultimately, it’s about bringing scientific rigour to digital health evaluation.
5. How do you see analytics tools evolving to keep pace with fast-moving technologies like GenAI and digital therapeutics?
Analytics tools must evolve from static dashboards to dynamic decision-support systems. With the rise of GenAI and next-gen digital therapeutics, the ability to analyse unstructured data, monitor real-time signals, and adapt taxonomies is no longer a luxury—it’s a necessity. We’re investing heavily in purpose-built AI that understands the nuances of healthcare and can surface context-rich insights in seconds. The future is conversational, predictive, and adaptive—where analytics don’t just answer questions but anticipate them. At Galen Growth, our mission is to ensure that as digital health matures, so too does the intelligence that powers it.
Thank you Julien!
